Clinical trials recruiting for Alzheimer's Disease
4
Recruiting trials
0
US states with sites
4
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 1Not applicable 3
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Conventional anti-dementia treatment group | 1 |
| KDS2010 | 1 |
| Lecanemab treatment group | 1 |
Self-screener
Recruiting trials
- Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)
- Evaluation of the Link Between Carotid Arterial Wall Viscosity and Major Neurocognitive Disorders
- Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease
- The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease
Related conditions
Trials recruiting for Alzheimer's Disease often also study these conditions. Each links to its own recruiting-trial list.
Alzheimer's disease 617Neurocognitive Disorders 11Mild Dementia 6Mild Cognitive Impairment (MCI) 27Dementia Alzheimer Type 8Alzheimer's Disease (AD) 5
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Alzheimer's Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.